This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
EFFECTIVENESS OF AGA, FUKUOKA AND EUROPEAN GUIDELINES IN THE MANAGEMENT OF INCIDENTALOMAS OF THE PANCREAS ANALYZED PRIOR TO PERFORMING ENDOSCOPIC ULTRASOUND WITH FINE NEEDLE PUNCTURE / EFICÁCIA DAS DIRETRIZES AGA, FUKUOKA E EUROPÉIA NO MANUSEIO DOS INCIDENTALOMAS MUCINOSOS DO PÂNCREAS ANALISADAS PREVIAMENTE À REALIZAÇÃO DA ULTRASSONOGRAFIA ENDOSCÓPICA COM PUNÇÃO POR AGULHA FINA
SciELO Preprints; dez. 2023.
Preprint
in Pt
| PREPRINT-SCIELO
| ID: pps-7736
Responsible library:
BR1.1
ABSTRACT
Introduction:
International consensus guidelines are commonly used to identify patients at high risk of developing cancer or with cancer. Its applicability, however, is based on investigation through imaging tests, however without histological confirmation.Objective:
To compare the performance and results of international guidelines in incidental mucinous neoplasia after diagnosis obtained by endoscopic ultrasound-guided fine needle puncture (EUS-PAF).Methods:
Single-center study with prospective collection of data from asymptomatic patients with the disease who underwent EUS-PAF. Appropriate cohort selection included images that were ambiguous regarding this diagnosis or the presence and/or development of other worrisome features as defined by international guidelines. After microhistological analysis of the material obtained, each of the guideline criteria was applied to identify cancer among patients with the disease.Results:
251 patients had the diagnosis confirmed by EUS-PAF or surgical procedure. The majority were asymptomatic. The final diagnosis revealed 27.8% (n=39) with malignant disease or high-risk signs. After applying the AGA-2015, IAP-2017 and DE-2018 criteria, it was observed that those detected incidentally were referred for surgery unnecessarily. These guidelines did not identify malignant and high-risk disease in 59%, 33.3% and 46.1%, respectively.Conclusion:
The European DE-2018 proved to be more accurate for use in patients with asymptomatic incidental mucinous neoplasia after the diagnosis obtained by EUS-PAF.RESUMO
Introdução:
Consensos internacionais, são diretrizes comumente usadas para identificar pacientes com alto risco de desenvolver câncer ou com câncer. Sua aplicabilidade, entretanto, baseia-se na investigação por exames de imagem, contudo sem confirmação histológica.Objetivo:
Comparar o desempenho e os resultados das diretrizes internacionais em neoplasia mucinosa incidental após diagnóstico obtido pela punção com agulha fina guiada por ultrassom endoscópico (USE-PAF).Métodos:
Estudo unicêntrico com coleta prospectiva de dados de pacientes assintomáticos com a doença submetidos a USE-PAF. A seleção apropriada da coorte incluiu imagens ambíguas quanto a esse diagnóstico ou a presença e/ou desenvolvimento de outras características preocupantes, conforme definido pelas diretrizes internacionais. Após análise microhistológica do material obtido, cada um dos critérios das diretrizes foi aplicado para identificar câncer entre os pacientes com a doença.Resultados:
251 pacientes tiveram o diagnóstico confirmado pela USE-PAF ou procedimento cirúrgico. A maioria era assintomática. O diagnóstico final revelou 27,8% (n=39) com doença maligna ou sinais de alto risco.. Após aplicação dos critérios AGA-2015, IAP-2017 e DE-2018, observou-se que os detectados incidentalmente foram encaminhados para cirurgia desnecessariamente. Essas diretrizes não identificaram doença maligna e de alto risco em 59%, 33,3% e 46,1%, respectivamente às diretrizes.Conclusão:
A DE-2018 europeia mostrou-se mais precisa para ser utilizada em pacientes com neoplasia mucinosa incidental assintomática após o diagnóstico obtido pela USE-PAF.
Full text:
1
Collection:
09-preprints
Database:
PREPRINT-SCIELO
Language:
Pt
Year:
2023
Document type:
Preprint